Diyala Journal of Agricultural Sciences, 10(Special issue): 35-46, 2018 Hashim et al. 

53 

 
1st Scientific Conf., College of Vet. Med.  Diyala Univ., 2018  

 

http://www.agriculmag.uodiyala.edu.iq/ 

 

PATHOLOGICAL STUDY AND GENETIC DIAGNOSIS OF 

VINBLASTINE EFFECTS ON DNA OF OVARY AND TESTES IN 

MOUSE   

Muna Sachit Hashim1,4   Suad Abdul-Kareem Mohammed 1 

Rabab Abd Almeer Naser2    Thikra Abdulla Mahmood3    Taghreed Jabbar Humadi1 

1Dept. of Pathology, College of Vet. Med., University of Baghdad, Iraq.   

2 Dept. of Anatom y, College of Vet. Med., University of Diyala, Iraq. 
3 Dept. of Communit y Medicine , College of Medicine , Kufa Universit y, Iraq.  

4Corresponding author: sachitmuna@yahoo.com 

ABSTRACT 

The present study was designed in order to identify the effects of 

vinblastine on ovary and testes and then on fertilization capacity and pregnancy 

outcome in white mice, fifty mixed mice were used, 10 treated male were mated 

with 10 untreated female, 10 untreated male were mated with 10 treated female, 

and (10) mixed mice as control. Results of male test showed decline in sperm 

count with spermatocytes' morphological deformity. The results of molecular 

technique applied on testicular section and ovarian section, showed that green 

signals, indicating the damage on TK (11qE2)/XY gene on chromosome of 

sperm and ova, red signal indicate intact gene yellowish signals indicated 

translocation on the same gene (mutation). Pathological findings showed marked 

loss of spermatogenesis (Azoospermia) with damage in testes' tissues; fibrosis of 

ovarian stroma with degenerative changes on ovary and evidence of early 

embryonic death with absence or low fertility. 

Key words: Vinblastine, mouse, DNA, ovary, testes. 

INTRODUCTION 

Vinblastine belongs to a group of medications known as vinca alkaloids and 

is obtained from the plant vinca rosea. Vinca alkaloids act as antimicrotubule 

agents that block mitosis by arresting cells in the metaphase. In Veterinary 

medicine, this agent represents the treatment of choice for canine transmissible 

venereal tumor (CTVT). The treatment is effective for 90% of CTVT cases, by 

intravenous (IV) administration, at the dose of 0.5-0.7 mg m-2 of body surface, 

once a week (Withrow, 2001). Vinblastine is safe for most patients, but potential 

side effects can occur, as gastro- intestinal alterations, myelosuppression and 

extravasation injury (Said, 2009) vinca alkaloids caused neurotoxicity involve 

peripheral, autonomic and central neuropathy (Graf, 1996). Neurotoxicity can 

persist for months after discontinuation of therapy in some patients, and in rare 

cases may be disabling (Egbelakin, 2011). Infants and embryos are at a higher 



Diyala Journal of Agricultural Sciences, 10(Special issue): 35-46, 2018 Hashim et al. 

53 

 
1st Scientific Conf., College of Vet. Med.  Diyala Univ., 2018  

 

http://www.agriculmag.uodiyala.edu.iq/ 

 

risk for experiencing Vinblastine-related neurotoxicity (Haskell, 1995). 

Peripheral neuropathy is the most common type of neuropathy and develops in 

almost all patients (McEvoy, 2004). Loss of deep tendon reflexes, peripheral 

paresthesia, pain and tingling can occur. If therapy is prolonged or high doses 

are administered, wrist and foot drop, ataxia, a slapping gait and difficulty in 

walking can occur. Cranial nerve toxicities may lead to vocal cord paresis or 

paralysis (hoarseness, weak voice), ocular motor nerve dysfunction (ptosis, 

strabismus), bilateral facial nerve palsies, or jaw pain. Severe jaw pain can occur 

within a few hours of the first dose of Vinblastine. Autonomic neuropathy 

results in constipation (which can be severe), abdominal pain, urinary retention 

and paralytic ileus. Central neuropathy includes headache, malaise, dizziness, 

seizures, mental depression and psychosis (Perry, 2001). 

Vinca alkaloids effects fertility 

Chemotherapeutic agents can initiate accelerates the reduction of the  

primordial follicle pool, induces ovarian atrophy and further a destruction of 

vascularization of the ovary which leads to ovarian damage and risk of 

premature ovarian failure, Follicular apoptosis and cortical fibrosis of ovaries 

are also assumed effects related to treatment with chemotherapy (Meirow, 

2010). Vinblastine therapy in female mouse caused defects in primary and 

secondary follicles and corpus lutetium with in depression follicular stimulating 

hormone (FSH) and luteinizing hormone (LH) and estrogen and progesterone 

(Al-Ahmed, 2010). Vinca alkaloids crossed the blood-Placenta barrier to 

produce cellular changes might play an important role in initiating growth 

defects and dead of embryo (Joneja, 1969 ; Hejazi, 2012). Vinca alkaloids 

reduced fertilization ability of male mice as results of DNA damage of sperm 

and so lead to sterile mating or pseudo-dominant-lethal effects. Researcher 

found that mice with vincristine treated father had a mutation rates up to twice 

that of mice with untreated fathers notably, these mutations were present in 

DNA inherited from both treated father and untreated mother, what this likely 

means according to the researches measures is that chemotherapy induces 

epigenetic changes in the sperm. Epigenetic Changes do not affect underlying 

DNA sequence but they alter chemical tags that control how genes are expressed 

this in turned to genome destabilization in the offspring, following sequence 

mutation to arise in DNA from the mother or father. The exact mechanism for 

genome destabilization and how it's inherited is unknown (Sarah, 2012). 

Suggesting impairment of epididymis function particularly concerning sperm 

maturation and endocytosis removal of contents of the cytoplasm droplets and 



Diyala Journal of Agricultural Sciences, 10(Special issue): 35-46, 2018 Hashim et al. 

53 

 
1st Scientific Conf., College of Vet. Med.  Diyala Univ., 2018  

 

http://www.agriculmag.uodiyala.edu.iq/ 

 

dead sperm (Averal, 1996). Male mouse treated with Vinca alkaloids for four 

separated period 2, 4, 6 and 8 weeks suffered from gradually loss of testes 

weight, sperm count, spermatocytes abnormalities with sever histopathological 

lesions on testes tissue represented by loss of spermatogenesis and dead sperm 

from apoptosis with inflammatory reaction further to necrosis (Al-Aamery, 

2013). 

MATERIALS AND METHODS 

Fifty mixed mice were kept in animal house of Veterinary Medicine 

College in Baghdad and fed on pellet for laboratory animal and provide with tap 

water in special tubes, 10 male and 10 female were injected with Vinblastine I/P 

(0.1 mg 10 gm-1 b.w) (Al-Aamery, 2013). 

For one month (4 weekly injection) and mated with 20 mixed untreated 

mice in separated groups. Other 10 mixed mice remained as control. After 

scarified animals, sperm specimens collection directly from epididymis and 

direct seminal fluid analysis was done (Al-Aamery, 2013). 

(Cooper, 2010). Testes and ovary section were prepared on a charge slides   

for molecular examination by using of FISH procedure to identify DNA damage 

on spermatocytes according to (Al-Aamery, 2013 ; Wyrobek, 2005 ; Galina, 

2010). Tissue specimen's testes and ovary were prepared for paraffin embedded 

sectioning and histopathological processing with staining methods was done 

(Slaoui, 2011). 

RESULTS AND DISSCUSION 

Results of fertility parameters in male and female 

The results of seminal fluid analysis showed in table 1, that there was rapid 

decrease in spermatocytes count with evidences of morphological deformities 

and loss of testes weight. The results of molecular test showed in table 2 that 

there was gradual and marked damage in DNA of sperm after 1st week of 

treatment with Vinblastine and be more evident after 4th week of treatment. The 

results of fertility parameters in females' mouse after treatment with Vinblastine 

showed in table 3, that there was loss of ovarian weigh with bad pregnancy 

outcome and visible loos in newborn with premature death of fetuses.  

 

 

 

 

 



Diyala Journal of Agricultural Sciences, 10(Special issue): 35-46, 2018 Hashim et al. 

53 

 
1st Scientific Conf., College of Vet. Med.  Diyala Univ., 2018  

 

http://www.agriculmag.uodiyala.edu.iq/ 

 

Table 1. Male fertility test 

Group and   

treatment time 

n=10 

Sperm count  

± s.d   6×10 

Abnormal 

spermatozoa % ± s.d 

Testes mean    

weight (mg)± s.d 

1-  1st  week 5.18±1.21A 22.5±10.1C 361±25.6 a 

2-  2nd  week 4.30±0.63B 30.1±11.4C 302±35.6 B 

3- 3rd  week 2.16±1.43B 47.5±11.7C 202±38.0 B 

4- 4th  week 1.28±0.63B 61.2±17.3C 108±33.6 B 

5-  Control 6.15±1.22 13.4±1.04 422±25.6 

Table 2. Molecular test for detection of DNA damage in ovary and testes 

Group and   

treatment 

time n=10 

Percentage of spermatocytes' 

DNA damage ( (% ±s.d) with 3 

score (Red, Green, Yellow) in 

ovary 

Percentage of DNA ovary (% 

±s.d) with 3 score (Red, Green, 

Yellow) in testes' tissue 

st week1-1 
Score1    score 2    score 3 

6             2            2   a 

score1      score2      score 

3              4              5 a 

nd week2-2 3             3            4   a 2              4              5 a 

rd week3-3 2             3            5   a  1              6              3 A 

th week4-4 0             2            8  A 0              1              9 B 

5- Control        8             2             0        9              1                0 

Differences from control are assessed by analysis of variance. Significant at:  a: p˂0.05; A: p˂0.01;  

B: p˂0.001 and assessed by the x2 test C: p˂0.001. Damage on DNA assed as: Score 1 (0-20%); score 

2(20-50%); score 3(50- above 95 %). 

Table 3. Females tested: for pregnancy outcome 

Fertility 

% 

Dead 

fetus 

Live 

fetuses 

Pregnant 

female 

% 

ovary mean  

weight  

(mg)±s.d 

Group  and 

treatments' 

time n=10 

62% a 22% 78% 8 (80%) 430  ± 12.5 1-1st week 

33% a 44% 56% 6 (60%) 333 ± 0.9 2- 2nd week 

12% a 59% 41% 3 (30%) 187 ± 2. 6 3- 3rd week 

2.2% a 88% 22% 1 (10%) 102 ± 1.25 4-4th week 

95% a 5% 95% 10(100%) 545 ± 11.6 5-cotrole 

Differences from control are assessed by analysis of variance. Significant at:  a: p ˂ 0.05.  

Vinblastine caused early loss of spermatogenesis with incidence of sperm 

defects and heavy drop in testes weight after few week of treatment that’s' 

proved and agreed with Al-Aamery (2013) and Dobrzynska (2003) in the same 

family of drug uses. As well as agreed with Marvin (2013) who said that’s 

chemotherapy causes reduction of sperm counts often to azoospermic levels that 

may persist for several years or be permanent. Females of mouse suffered from 

ovarian loss of weight due to ovarian hypoplasia with increase percent of 

immature deliver baby with dead or defected fetuses that’s' lead to pad 



Diyala Journal of Agricultural Sciences, 10(Special issue): 35-46, 2018 Hashim et al. 

53 

 
1st Scientific Conf., College of Vet. Med.  Diyala Univ., 2018  

 

http://www.agriculmag.uodiyala.edu.iq/ 

 

pregnancy outcome and this agreed with (Hejazi, 2012). Who said that the 

similar family drug vincristine has teratogenicity effects on the fetus as well as 

clinical effects. Also agreed with studies based on the penetration of the drug 

through blood-fetus and the cause of birth defects (Aigraina, 2005 ; Sadler, 

2000).     

Results of microscopic appearance 

1-Molecular examination: was done by the application of florescence's in situ 

hybridization (FISH) method and procedure on mouse samples testes and ovary 

according to (Al-Aamery, 2013). Green signals in testes and ovary represented 

the damage in site of TK (11qE2) / XY gene of sperm; Yellow signals refer to 

mutation or translocation in the gene. Red signal represented the controls' 

sample Figure 1 "A, B, C and D". 

 

 
Fig. 1. A. testes section   B. ovary section   C. red signal of control     D. yellow signal 

The results of molecular test (FISH) examined the defect on DNA of 

spermatocytes and ovary by calculating signals' percent referring to 

chromosomal damage on TK (11qE2) /Y gene of sperm and ovary. Results 

agreed with Al-Aamery (2013) who study the same effects of vincristine on 

DNA'S sperm of mouse and with Wyrobec (2005) who use the same test.   

2- Histopathological examination 

Testes sections shows empty of seminiferous tubules (A) due to loose of 

spermatogenesis with degenerative changes represented by hydropic 

degeneration (B) with necrosis involve dead sperm and endothelial cells falls 

into lumen (C) figure 2. In comparison with normal seminiferous filled tubules 

(Figure 3). 

A B 

C 
D 



Diyala Journal of Agricultural Sciences, 10(Special issue): 35-46, 2018 Hashim et al. 

04 

 
1st Scientific Conf., College of Vet. Med.  Diyala Univ., 2018  

 

http://www.agriculmag.uodiyala.edu.iq/ 

 

 

 

Fig. 2. Testes treated with Vinblastine showed empty seminiferous tubules (A) refer to 

loss of spermatogenesis, with dilated and congested blood vessel (B) and necrosis (C) 

(H&E 40X) 

 
Fig. 3. Testes (control) showed spermatocytes filled seminiferous tubules (H&E 10X) 

The pathological finding of females sections showed, that there's an 

evidence of uterine fibrotic lesions involves endometrium (Figure 4. "A and B"). 

With atrophic and necrotic endometrial glands with glandular' epithelial lining 

metaplasia and hyperplasia (Figure 5. "A and B"). Ovarian section of mouse 

showed failure of ovulation at the end of 4 week of treatment with Vinblastine 

with fibrotic lesions involves primary and secondary follicles within ovarian 

stroma and hydropic degeneration (Figure 6). 

B 

A 

C 



Diyala Journal of Agricultural Sciences, 10(Special issue): 35-46, 2018 Hashim et al. 

04 

 
1st Scientific Conf., College of Vet. Med.  Diyala Univ., 2018  

 

http://www.agriculmag.uodiyala.edu.iq/ 

 

 

 
Fig. 4. A. Uterus section of mouse showed cystic edematous degenerated endometrial 

gland (A) with coagulative necrosis (B) (H&E 10X) 

 
Fig. 4. B. Uterus section of mouse showed fibrosis (Black arrow) and comprised atrophic 

degenerated glands (Red arrow) within endometrium (H&E 40X) 

A 

B 



Diyala Journal of Agricultural Sciences, 10(Special issue): 35-46, 2018 Hashim et al. 

04 

 
1st Scientific Conf., College of Vet. Med.  Diyala Univ., 2018  

 

http://www.agriculmag.uodiyala.edu.iq/ 

 

 
Fig 5. A. Uterus showed atrophic and necrotic endometrial glands (A) with glandular' 

lumen epithelial lining (B) metaplasia and hyperplasia with papillary projection (H&E 

10X) 

 

 

 
Fig. 5. B. Uterus showed vacuolated glands (black arrow) with glandular lumen 

distention with papillary projection from metaplasia and hyperplasia (Red arrow) 

(H&E 10X) 

B 

A 



Diyala Journal of Agricultural Sciences, 10(Special issue): 35-46, 2018 Hashim et al. 

05 

 
1st Scientific Conf., College of Vet. Med.  Diyala Univ., 2018  

 

http://www.agriculmag.uodiyala.edu.iq/ 

 

 
Fig. 6. Ovarian showed early degenerative changes on follicles with failure of ovulation 

(Red arrow) at the end of 4 week of treatment with vinblastine; fibrotic lesions (black 

arrow) involves ovarian stroma with hydropic degeneration (A) (H&E 40X) 

Vinblastine has toxic effects on mouse reproductive organs represents by 

losing of spermatogenesis, vacuolation and necrosis within seminiferous tubules 

and fibrosis in an advance stages, this effects increased with increased time of 

treatments, and attributed to the pharmakinetic factor of drugs that’s caused 

early pass of drug through blood testes barrier (BTB) and exerts it's toxicity as 

soon as contact with testicular cells mainly leydig cells, sertoli cells, germs cells 

so there's' evidence of oligospermia, azoospermia, and germinal aplasia. This 

study's' results agreed with what found by (Al-Aamery, 2013 ; CC Lu,1979 ; 

Roeser, 1998 ; Fairly, 1999). In female we found that s' vinblastine caused 

severe fibrotic lesions within atrophic uterus and ovary, that's caused failure  in 

successful fertilized  ova due to lose of mature follicles, lead to bad outcome of 

pregnancy which increased with increased time of treatment. Beside the 

immature parturition or early delivery with dead or defects fetuses. And this 

agreed with Hejazi, 2012 ; Dobrzyńska, 2005 ; Karen, 2009). 

CONCLUSION 

 A chemicals drug affects both histological and genetics structures of ovary 

and testes.    

REFERENSCES 

Aigraina, E. J. and G. Korenb. 2005. Effects of drugs on the fetus. Seminars in 

Fetal and Neonatal Medicine, 10: 139-147. 



Diyala Journal of Agricultural Sciences, 10(Special issue): 35-46, 2018 Hashim et al. 

00 

 
1st Scientific Conf., College of Vet. Med.  Diyala Univ., 2018  

 

http://www.agriculmag.uodiyala.edu.iq/ 

 

Al-Aamery, Muna, S. H. 2013. Molecular, Pathological and Immunological 

Study of Vincristine Sulfate Effects in White Male Mice and Rats. Pp: 59-

154. Ph. D. Thesis. College of Vet. Med., University of Baghdad. 

Averal, H. I., A. Stanley, P. Murugaian, M. Palanisamy and M. A. Akbarsha. 

1996. Specific effect of Vinca alkaloids on epididymis. Indian. J. Exp. Biol. 

Jama: 34: 53-60. 

CC Lu and M. L. Meistrich. 1979. Cytotoxic effects of chemotherapeutic drugs 

on mouse testis cells. Cancer Research (Impact Factor: 8.65). 10/1979; 

39(9): 3575-82, source: Pub Med.   

Cooper World Health Organization. 2010. Department of Reproductive Health 

and Research world health organization Laboratory Manual For the 

Examination and processing of human semen 5th ed, world health 

organization, Geneva, Switzerland.  

Dobrzyńska, M. M., U. Czajka and M. G. Słowikowska. 2005. Reproductive 

effects after exposure of mice to vincristine and to a combination of X-rays 

and vincristine. Reprod. Fertil. Dev. 17(8):759-671. 

Dobrzynska, M. M. 2003.The change in the quantity and in the quality to semen 

and sperm following sub chronicc exposure of mice to chemotherapy: In 

Human Monitoring for Genetic effect. Edsm a, cebulska-wasilewaska, W. 

W. Au and R. J. Sram Clos. press: Amsterdam, the Netherlands. PP: 309-

317. 

Egbelakin, A. 2011. Increased of Vinca alkaloids neurotoxicity associated with 

low CYP3A5expretion genotype in children with acute lymphoblastic 

leukemia. pediatr. blood cancer, 56: 361-367. 

Fairly, K. F., J. U. Barrie and W. Johnson. 1999. Sterility and testicular atrophy 

related to chemotherapy. Lancet, 1: 568. 

Galina, G. Hovhanisyan. 2010. Fluorescence insitu hybridization with comet 

assay and micronucleus. Test in genetic toxicology. Molecular 

cytologenetics, 3: 17, hovgalina@List.ru. 

Graf, W. D., P. F. Chance, M. W. Lensch, L. J. Eng, H. P. Lipe and T. D. Bird. 

1996. Severe Vinca alkaloids neuropathy in Charcot-Marie-Tooth Disease 

type 1A. Cancer, 77(7): 1356-1362. 

Haskell, C. 1995. Antineoplastic Agents. In: Cancer Treatment. Philadelphia: 

W.B. Saunders Company. 

Al-Ahmed, Hazim I. A. 2010. Effect of some chemotherapy drugs vincristine 

and vinblastine on females albino mice fertility and sex hormones level. 



Diyala Journal of Agricultural Sciences, 10(Special issue): 35-46, 2018 Hashim et al. 

03 

 
1st Scientific Conf., College of Vet. Med.  Diyala Univ., 2018  

 

http://www.agriculmag.uodiyala.edu.iq/ 

 

Journal of Biotechnology Research Center. 4(2). Biotechnology Research 

Center/Al-Nahrain University. 

Hejazi, Sajjad and Jahangir-Fard Ramin. 2012. The Toxicity Study of Vinca 

alkaloids on Foeti of Pregnant Mice. 1Department of Basic Sciences, 

Tabriz Branch, Islamic Azad University, Tabriz, Iran 2Faculty of 

Veterinary Medicine, Tabriz Branch, Islamic Azad University, Tabriz, Iran. 

Middle-East Journal of Scientific Research 12(3): 322-324. ISSN 1990-

9233. 

Joneja, M. and S. Ungthavorn. 1969. Teratogenic effects of Vinca alkaloids in 

three lines of mice. Teratol., 2: 235-240. 

Karen, D., M. D. Wright, M. Daniel M. D. Green and Najat C. Daw, MD. 2009. 

Effects of Treatment for Wilms Tumor. Pediatr Hematol Oncol. 26(6): 

407-413.  

Marvin L. Meistrich. 2013. Effects of chemotherapy and radiotherapy on 

spermatogenesis in humans. Department of Experimental Radiation 

Oncology, University of Texas M. D. Anderson Cancer Center, Houston, 

Texas. Electronic address: Fertility and sterility 09/2013; DOI: 10.1016/j. 

fertnstert. 2013.08.010 Source: PubMed. 

McEvoy, G., editor. 2004. American Hospital Formulary Service. Bethesda: 

American Society of Health-System Pharmacists. 

Meirow, D., H. Biederman, R. A. Anderson and W. H. Wallace. 2010. Toxicity 

of chemotherapy and radiation on female reproduction. Clin Obstet 

Gynecol. 53(4): 727-39. 

Perry, M. 2001. The Chemotherapy Source Book. Philadelphia: Lippincott 

Williams and Wilkins, p. 489-90. 

Roeser, H. P., A. E. Stocks and A. J. Smith. 1998. Testicular damage due to 

cytotoxic drug and recovery after cessation of therapy. Aust. N. Z. J. 8: 250. 

Said, R. A., L. F. Silva, A. R. O. L. Albuquerque, E. M. Sousa-Neta and M. O. 

Lavinsky. 2009. Efficacy and side effects of Vinca alkaloids treatment on 

Canine Transmissible Venereal Tumor-438. UESC/Hospital Veterinário, 

Rod. Ilhéus-Itabuna, Km 16, Salobrinho. Ilhéus/ BA, 45662-000, Brazil. E-

mail: roueda@uol.com.br. 

Slaoui, M., and L. Fiette. 2011. Histopathology procedures: from tissue 

sampling to histopathological evaluation. Histopathology Methods Mol. 

Biol. 691: 69-82. 

Sadler, T. W. 2000. Longman’s Medical Embryology. 9th ed., Lippincott, pp: 

120-121. 



Diyala Journal of Agricultural Sciences, 10(Special issue): 35-46, 2018 Hashim et al. 

03 

 
1st Scientific Conf., College of Vet. Med.  Diyala Univ., 2018  

 

http://www.agriculmag.uodiyala.edu.iq/ 

 

Sarah, C. P. and R. Williams Woods. 2012. Chemotherapy in parents may make 

offspring's DNA unstable and riddled with mutations. Genetics: Searching 

for answers. Hum. Mol. Genet. 21: 2399-2411. 

Wyrobek, J. Andrew, E. Thomas and F. M. Schmid. 2005. Cross-Species-

Sperm-FISH. Assays paternal Risk for chromosomally abnormal 

pregnancies. Environ. mol. Mutag. 45: 271-283. 

Withrow, J. S. and E. G. Macewen. 2001. Transmissibl Venereal Tumor, p.184, 

533-537, 799-802, In: Withrow J. S. and Vail D. (Ed.) Small Animal 

Clinical Oncology. Philadelphia, WB Saunders. 

 

 دنا المبيض والخصى في الفئران البيضاء فيمرضية في تأثيرالفنبالستين -نسيجية-دراسة جزيئية

 2رباب عبداالمير                           1سعاد عبدالكريم محمد                     1،4منى ساجت هاشم

 1تغريد جبارحمادي              3ذكرى عبدهللا محمود

 قسم األمراض، كلية الطب البيطري، جامعة بغداد، العراق 4
 قسم التشريح، كلية الطب البيطري، جامعة ديالى، العراق. 4 

 كلية الطب، جامعة الكوفة، العراق.قسم طب المجتمع،  5

 sachitmuna@yahoo.com ن النشر:المسؤول ع 0

 المستخلص

عاقبة األخصاب  فيالمبايض والخصى ومن ثم  فيتأثيرالفنبالستين معرفة لصممت الدراسة الحالية 

( 10) معاملة زوجت مع ( ذكور10)، ( فأرا مختلطا50) خمسوناستعمل . والحمل في الفئران البيضاء

فئران مختلطة  (10)وتركت  ناث معاملةإ 10)زوجت مع ) ذكورغيرمعاملة (10)، وناث غيرمعاملةإ

 هبوط في حساب النطف مع تشوهات شكلية في الخاليا المنوية. نتائج فحوصات الذكورأظهرت  كسيطرة.

شارة  الخضراء عبرت عن نتائج التقنية الجزيئية المطبقة على أنسجة الخصى والمبايض أظهرت بأن اإل

شارة الصفراء عبرت عن تغيرموقع اإلو االشارة الحمراء عبرت سالمة الجينوالتلف الحاصل في الجين 

)انعدام النطف( مع تلف في أنسجة  تكوين النطف )الطفرة(. أظهرت المشاهدات المرضية فقد الجين

جنين المبكرمع انعدام او قلة التليف المبيض مع تغيرات تنكسية في المبيض وحدوث موت و ،الخصى

 .نسبة االخصاب

   الخصى.، المبايضفأر، الحامض النووي،  ،فنبالستين لكلمات المفتاحية:ا